ASSAY and Drug Development Technologies

Editor-in-Chief: Bruce J. Melancon, PhD

ISSN: 1540-658X | Online ISSN: 1557-8127 | 8 Issues Annually | Current Volume: 20

Impact Factor: 1.738 2020 Journal Citation Reports (Clarivate, 2021)

CiteScore™: 2.1

Delivering the latest industry insight into innovative early-stage research, techniques, and tools for optimizing new pharmaceutical development.

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts View Submission Instructions Share with a Colleague

Announcements

Virtual Collection: Coverage of COVID-19

This virtual collection is dedicated to COVID-19 drug repurposing, drug development, and drug discovery peer-reviewed content.

Access the Virtual Issue
Free eBook Download:
Biomarkers, Screening, and Advances in Drug Discovery Workflow

Featured Content

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.